DGEN
Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2007 Q2 | -0.00 | $617,000 | $336,000 |
| 2007 Q1 | -0.01 | $358,000 | -$1M |
| 2006 Q4 | 0.06 | $3M | $2M |
| 2006 Q3 | 0.00 | $970,000 | -$1M |
| 2006 Q2 | 0.04 | $4M | $1M |
| 2006 Q1 | 0.01 | $2M | $246,000 |
| 2003 Q1 | -0.45 | $5M | -$16M |
| 2002 Q4 | -0.54 | $5M | -$25M |